Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Feb. 01, 2020	Feb. 02, 2019	Feb. 03, 2018
OPERATING ACTIVITIES
Net income	$ 35,897,000	$ 30,461,000	$ 8,540,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	15,485,000	16,463,000	19,643,000
Provision For Doubtful Accounts	524,000	470,000	690,000
Purchase premium and premium amortization	(694,000)	576,000	3,834,000
Share Based Compensation	4,669,000	4,939,000	4,196,000
Excess tax benefits from share-based compensation	0	0	0
Deferred income taxes	2,120,000	1,285,000	1,176,000
Loss on disposal of property and equipment	837,000	1,089,000	2,127,000
Impairment	470,000	1,548,000	7,698,000
Changes in operating assets and liabilities which provided (used) cash:
Accounts receivable	1,525,000	(579,000)	1,780,000
Merchandise inventories	4,220,000	1,950,000	24,147,000
Prepaid and other assets	5,072,000	10,384,000	(7,459,000)
Operating lease right-of-use asstes and liabilities	(9,803,000)	0	0
Accrued income taxes	1,703,000	(680,000)	(1,602,000)
Accounts payable, accrued expenses and other liabilities	(8,629,000)	(7,662,000)	(28,780,000)
Net cash provided by operating activities	53,396,000	60,244,000	35,990,000
INVESTING ACTIVITIES
Capital expenditures	(8,306,000)	(4,354,000)	(11,096,000)
Purchase of short-term investments	(218,345,000)	(157,515,000)	(15,770,000)
Sales of short-term investments	205,375,000	91,023,000	95,203,000
Purchase of Other Assets	(1,353,000)	(298,000)	(657,000)
Sales Of Other Assets	4,000	(7,000)	(6,000)
Net cash used in investing activities	(22,633,000)	(71,137,000)	67,686,000
FINANCING ACTIVITIES
Dividends paid	(32,592,000)	(32,577,000)	(33,731,000)
Repurchase of common stock	(9,605,000)	(13,344,000)	(38,878,000)
Proceeds from lines of credit	0	0	21,000,000
Payments to lines of credit	0	0	(21,000,000)
Proceeds from employee stock purchase plan	626,000	570,000	484,000
Proceeds From Stock Options Exercised	0	189,000	95,000
Net cash provided used in financing activities	(41,571,000)	(45,162,000)	(72,030,000)
Net increase in cash and cash equivalents	(10,808,000)	(56,055,000)	31,646,000
Cash, Cash Equivalents and Restricted Cash at Beginning of Period	25,209,000	81,264,000	49,618,000
Cash, Cash Equivalents and Restricted Cash at End of Period	14,401,000	25,209,000	81,264,000
Change in Accrued PPE	2,828,000	326,000	634,000
Change in Accrued Treasury Stock	$ 818,000	$ 0	$ 0